Case Studies Advanced Heart Failure and the Role of Mechanical Circulatory Support Megan Shifrin, RN, MSN, ACNP-BC Vanderbilt University.

Slides:



Advertisements
Similar presentations
Advanced Heart Failure and the Role of Mechanical Circulatory Support
Advertisements

BACK TO BASICS: PHARMACOLOGY CHAD C. CRIPE, MD Department of Anesthesiology & Critical Care Medicine Division of Cardiothoracic Anesthesiology The Children’s.
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Ryan Hampton January  Risks and benefits of surgery  Timing of surgery  Type of Surgery  Goal is to uncover undiagnosed problems or treat prior.
Outcome of Patients with Advanced Heart Failure who Receive Device- Based Therapy for Primary Prevention of Sudden Cardiac Death, G. Amit, N. Samniah,
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Preliminary results from the C-Pulse OPTIONS HF European Multicenter Post-Market Study Holger Hotz, CardioCentrum Berlin, Berlin, Germany; Antonia Schulz,
© 2000 Heart Failure Society of America, Inc.
Between May 2013 and June 2014, we implanted the C-Pulse device in 7 male and 1 female patients with a mean age ± SD of 61.1 ± 9.4 years. Four had ischemic.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Heart Failure Chloe Hymers and Morag Sime. Aim Know the difference between left and right heart failure Be able to take a history specific to heart failure.
Left Ventricular Assist Devices: The What and the Who Lance E. Sullenberger MD FACC FACP Capital Cardiology Associates.
E LECTROCARDIOGRAM AND THE D IAGNOSIS OF C ONGESTIVE H EART F AILURE By Angela Thomas.
Mechanical Circulatory Support for Advanced Heart Failure Speakers: Lynne A Benish, ACNP-BC Mechanical Assist Device Nurse Practitioner, Cardiac Surgery.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Mr. J is a 70 year old man with an ischemic cardiomyopathy who presents with class III CHF and significant dissatisfaction with his functional capacity.
Heart Failure Medicines ACE (angiotensin- converting enzyme) inhibitors ARBs (angiotensin receptor blockers) Beta-blockers Spironolactone Diuretics (water.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Dilated Cardiomyopathy
Supporting Patients with CHF Care Transformation Collaborative of R.I. MAUREEN CLAFLIN, MSN, RN. NCM UNIVERSITY MEDICINE GOVERNOR STREET PRIMARY CARE CENTER.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Perioperative Testing
Congestive Heart Failure!!. Question 1 What’s a symptom of congestive heart failure?? A. shortness of breath B. chest pain C. No appetite D. all of the.
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Assessment.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Heart Failure (HF) : Overview Common underlying heart diseases or causes of HF 1.Valvular HD-Rheumatic etiology 2.Cardiomyopathy – Dilated type 3.Ischemic.
Hypertension (High Blood Pressure)
Heart Failure: Interactive Fundamental Clinical Reasoning Activity
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
Angina & Dysrhythmias. A & P OF THE CARDIAC SYSTEM Cardiac output  CO=SV(stroke volume) X HR(heart rate) Preload  Volume of blood in the ventricles.
Cardiac Failure Richard Price Richard Price Consultant, Intensive Care, RAH. Consultant, Intensive Care, RAH.
Nursing and heart failure
Bipyridines :(Amrinone,Milrinone ) only available in parenteral form. Half-life 3-6hrs. Excreted in urine.
Cardiogenic Shock Dr. Belal Hijji, RN, PhD October 12 & 15, 2011.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
TREATMENT OF HEART FAILURE From Oral Medications to Intravenous Drips Mark Puhlman MSN ANP.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Heart Failure Clinic Facility: James A Haley VAMC, Tampa FL Contact Person: Jeannette McCain, MA, ARNP-C
Circulatory Failure - Shock. Case Presentation 56 year old man with a past history of type 2 diabetes and hypertension. Presented to the ER with a 12.
Heart Failure: ACC Guidelines for Dx and Management Steven W. Harris MHS PAC.
“Rise of the Machines” Todd D. Edwards MD FACC FACP FASNC.
Case 60 F with PMH HTN, DM, CVA presented to UNC ED CC: seizure. Per the daughter the pt was walking and all of a sudden fell and her whole body started.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
Internal Medicine Workshop Series Laos September /October 2009
Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.
Natural History of Heart Failure
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
The Role of Health Information Technology in Implementing Disease Management Programs Donald F. Wilson, MD Medical Director Quality Insights of Pennsylvania.
Management of Heart Failure Dr. M.Kheir Mulki. What is the definition of Heart Failure ?
Therapeutics IV Tutoring May 6, 2016 Lisa Hayes
Internal Medicine Workshop Series Laos September /October 2009.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
University of Cincinnati Medical Center
CASE HISTORY ISCHEMIC HEART DISEASE
Cholesterol practice questions
Congestive heart failure
Step Care Therapy for Hypertension in Diabetic Patients
Mechanical Circulatory Support Devices HOSEIN PASANDI.
RCHC’s Cardiovascular Health Initiative
Section III: Neurohormonal strategies in heart failure
Train-the-Trainer Cases
Internal Medicine Workshop Series Laos September /October 2009
Train-the-Trainer Cases
Train-the-Trainer Cases
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

Case Studies Advanced Heart Failure and the Role of Mechanical Circulatory Support Megan Shifrin, RN, MSN, ACNP-BC Vanderbilt University

Case Study #1 JK is a 58 year old male with a PMH of HTN, HLD, DM II (A1c 7.4), asthma, and myocardial infarction in At the time of his MI, he was found to have multi-vessel coronary artery disease and underwent a CABGx4 (2009). Over the past four years, his LVEF has decreased from 45% to 25%, and he currently has NYHA class IV symptoms. He presents to you today in clinic for his regularly scheduled follow-up appointment. He reports being mostly home-bound with the exception of going to his son’s high school football games on Friday nights. He describes having dypnea and diaphoresis when carrying out ADLs such as bathing and dressing. He is able to ambulate approximately 20 feet at a time. His physical exam is notable for 2+ lower and upper extremity edema; S3 on auscultation to his heart sounds, and crackles in his bilateral lung fields.

Based on the cast study presented, JK’s heart failure would fall into which of the following categories: A.Ischemic cardiomyopathy B.Non-ischemic cardiomyopathy

Based on JK’s past medical history, which of the following is likely NOT to be contributory to his ischemic cardiomyopathy? A. Diabetes B. Hypertension C. Asthma D. Hyperlipidemia

Based on JK’s past medical history and LVEF of 25%, which of the following classes of medications are NOT supported by the literature (Strength of evidence = A)? A. Beta Blockers B. ACE Inhibitors C. Calcium Channel Blockers D. Loop diuretics

You, in conjunction with the collaborative heart failure team, believe that it is time to start outpatient inotropic support. Which TWO of the following medications are FDA approved for outpatient use in heart failure? A. Epinephrine B. Dopamine C. Dobutamine D. Milrinone

The heart failure team is considering ICD placement in JK. You know that an ICD is warranted in JK due to all of the following reasons EXCEPT: A)His past medical history of DM II B)His LVEF < 35% C)For primary prevention of arrhythmias D)His history of heart failure (ischemic etiology)

Case Study #2 LN is a 34 year old female with a past medical history of peripartum cardiomyopathy following the vaginal delivery of her first child nine months ago. Her LVEF is 20%, and she has NYHA class IV symptoms. She has been on optimal medical therapy including carvedilol, captopril, aldactone, and lasix. In addition, she was started on an outpatient milrinone infusion at 0.25 mcg/kg/min one month ago. She has been listed for heart transplantation, but due to her blood type of A- and her body habitus, it is unlikely that a donor heart will be found quickly.

Based on the cast study presented, LN’s peripartum cardiomyopathy would fall into which of the following categories: A. Ischemic cardiomyopathy B. Non-ischemic cardiomyopathy

LN is undergoing evaluation for LVAD placement. Based on the case study, LN would fall into which LVAD category? A) Destination therapy B) Bridge to transplantation C) Bridge to nowhere D) Bridge to decision

LN asks about the benefits of having an LVAD placed. Which of the following statements is TRUE regarding LVAD placement as a bridge to transplantation? A) Patients are guaranteed a transplant if they get a LVAD B) Most LVAD patients see an improvement in their ability to carry out their usual activities of daily living C) A LVAD will make her heart failure resolve D) She will be able to stop all of her heart failure medication shortly after LVAD placement

Some of the long-term risks associated with LVAD placement include which of the following: A) Infection B) GI bleed C) CVA D) All of the above

As the ACNP preparing to care for LN in the immediate post-operative period, you recognize that the following issues will likely be present: A) LN may be afterload sensitive B) LN may be preload sensitive C) LN will likely be pulseless due to her continuous flow LVAD D) All of the above

If LN’s heart failure continues to advance, you know that it’s an easy decision to throw her on a short-term VAD such as a TandemHeart or CentriMag. A.True B.False